Physician profile
Steven Krause
NPI 1386628519
$3,706.26
in general payments reported to CMS, 2019-2025
30 companies · $501 in 2025
The $501 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,026 · 2020: $927 · 2021: $451 · 2022: $244 · 2023: $404 · 2024: $153 · 2025: $501.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,058.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,057.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,289.01 | 2019-2025 | Amplatzer Amulet, Esprit |
| Novartis Pharmaceuticals Corporation | $530.04 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $350.32 | 2019-2025 | Lifevest |
| Medtronic, INC. | $182.03 | 2021-2023 | Linq II |
| Shockwave Medical, INC | $172.04 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Janssen Pharmaceuticals, INC | $155.31 | 2019-2023 | Xarelto |
| Amgen INC. | $112.66 | 2019-2025 | Repatha |
| E.R. Squibb & Sons, L.L.C. | $102.84 | 2019-2024 | Camzyos |
| Pfizer INC. | $94.47 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $86.00 | 2019-2022 | |
| Actelion Pharmaceuticals US, INC. | $68.57 | 2019 | |
| Biotronik INC. | $66.84 | 2022 | |
| Lundbeck LLC | $64.18 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $54.52 | 2019 | |
| Gilead Sciences, INC. | $53.11 | 2019 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $50.64 | 2019-2020 | |
| Abiomed | $31.94 | 2023 | Impella |
| Irhythm Technologies, INC. | $31.01 | 2022-2024 | Zio Monitor, Zio Xt Patch |
| Heartflow, INC. | $28.84 | 2024 | |
| Inari Medical, INC. | $23.48 | 2021 | |
| Terumo Medical Corporation | $22.32 | 2025 | Angio-Seal |
| Cardiovascular Systems INC. | $18.78 | 2022 | |
| Novo Nordisk INC | $18.71 | 2025 | Wegovy |
| Inspire Medical Systems, INC. | $17.59 | 2025 | Inspire |
| Cardiva Medical, INC. | $15.81 | 2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Medtronic Vascular, INC. | $14.89 | 2019 | |
| Venturemed Group, INC. | $13.60 | 2022 | |
| Zoll Circulation INC | $12.99 | 2025 | Downstream Cartridge, Therox Ds2 Console, Catheter |
| Bayer Healthcare Pharmaceuticals INC. | $12.79 | 2023 | |
| Angiodynamics, INC. | $10.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Krause listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.